Reviews
Nitric oxide mechanisms of nebivolol.
Maffei A, Lembo G.
Ther Adv Cardiovasc Dis. 2009 Aug;3(4):317-27. Epub 2009 May 14. Review.
Mechanisms of cardiac hypertrophy.
Selvetella G, Lembo G.
Heart Fail Clin. 2005 Jul;1(2):263-73. Review. No abstract available.
Insulin resistance and cardiovascular risk: New insights from molecular and cellular biology.
Morisco C, Lembo G, Trimarco B.
Trends Cardiovasc Med. 2006 Aug;16(6):183-8. Review.
Hirsch E, Lembo G, Montrucchio G, Rommel C, Costa C, Barberis L.
Thromb Haemost. 2006 Jan;95(1):29-35. Review.
Integrin signalling: the tug-of-war in heart hypertrophy.
Brancaccio M, Hirsch E, Notte A, Selvetella G, Lembo G, Tarone G.
Cardiovasc Res. 2006 Jun 1;70(3):422-33. Epub 2006 Feb 8. Review. Erratum in: Cardiovasc Res. 2006 Dec 1;72(3):494.
Adaptive and maladaptive hypertrophic pathways: points of convergence and divergence.
Selvetella G, Hirsch E, Notte A, Tarone G, Lembo G.
Cardiovasc Res. 2004 Aug 15;63(3):373-80. Review.
Alloatti G, Montrucchio G, Lembo G, Hirsch E.
Biochem Soc Trans. 2004 Apr;32(Pt 2):383-6. Review.
Molecular interplay between mechanical and humoral signalling in cardiac hypertrophy.
Tarone G, Lembo G.
Trends Mol Med. 2003 Sep;9(9):376-82. Review.
Erythrocyte-derived depressing factor: a novel cardiovascular player?
Selvetella G, Maffei A, Lembo G.
J Hypertens. 2003 Jun;21(6):1087-8. Review. No abstract available.